Navigation Links
Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
Date:1/3/2008

CRANBURY, N.J., Jan. 2 /PRNewswire-FirstCall/ -- Amicus Therapeutics Inc. (Nasdaq: FOLD), today announced that John F. Crowley, President and Chief Executive Officer, will present a corporate update at the 26th Annual JPMorgan Healthcare Conference in San Francisco, CA on Monday, January 7, 2008 at 11:30 am (Pacific Standard Time) at the Westin St. Francis Hotel.

The presentation will be webcast live and may be accessed by visiting Amicus' website at http://www.amicustherapeutics.com. A replay of the webcast will also be available on the Company's website until January 22, 2008.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease. The Company has completed Phase 1 clinical trials of AT2220 for the treatment of Pompe disease.

Forward-Looking Statements

Amicus cautions you that statements included in this press release that are not a description of historical facts are "forward-looking statements" within the meaning of Section 21E of the Private Securities Litigation Reform Act of
'/>"/>

SOURCE Amicus Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
2. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
3. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... LAWRENCEVILLE, N.J. , March 5, 2015 /PRNewswire/ ... today that the Company will host a conference ... provide an update on its development programs for ... and two newly acquired technology platforms, TheraPlas™ and ... a.m. ET on Thursday, March 12, 2015. To ...
(Date:3/5/2015)... and Markets ( http://www.researchandmarkets.com/research/4q7gwz/india_pharma ) has announced ... Accelerating growth to the next level - Moving up ... offering. Domestic sales improved in 2014, ... the market,s reaction to the new drug pricing policy. ... healthy, as the momentum continues and improving economic growth ...
(Date:3/5/2015)... HAMPTON, N.J. , March 5, 2015 /PRNewswire/ ... ), a leading global specialty biopharmaceutical company, and Ikaria, ... they have entered into a definitive agreement under which ... a Madison Dearborn -led investor group in a ... Subject to customary closing conditions, the parties expect the ...
Breaking Medicine Technology:Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9
... 2, 2012  Trovagene, Inc. (Pink Sheets: TROV ... of a diagnostic test to determine the presence of ... specimens. The proprietary test (U.S. patent application pending) might, ... carrier status in males. The Company,s HPV ...
... Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical ... central nervous system disorders and pain, announced today that ... to the U.S. Food and Drug Administration (FDA) for ... candidate for the treatment of chronic pain.     ...
Cached Medicine Technology:Trovagene Announces Plans to Develop Proprietary Test for High Risk HPV Carrier Screening from Urine 2Trovagene Announces Plans to Develop Proprietary Test for High Risk HPV Carrier Screening from Urine 3Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 2Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 3Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 4Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 5Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 6
(Date:3/5/2015)... Developers and plugin specialists of ... new transition pack entitled TranSlice Wipe for FCPX. , ... with ease while maintaining a professional look,” Said Christina ... a time saver with transitions our users will love.” ... split screen transitions with a new style. TranSlice Wipe ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Aureus Medical ... including locum tenens and direct hire physician jobs, has ... the Nebraska Academy of Family Physicians 67th Annual Meeting ... in La Vista, Nebraska. , The Annual Meeting ... to learn, networking opportunities, and an exhibition of products ...
(Date:3/5/2015)... Yorba Linda, CA (PRWEB) March 05, 2015 ... Professor of Neuroscience, Professor of Psychiatry and Psychology ... a keynote presentation at the upcoming BioConference Live ... in neuroscience. , The webcast , ... Schizophrenia and Depression,” is scheduled for Thursday, March ...
(Date:3/5/2015)... 2015 The pleasing melodies of live bluegrass ... of America bicycle and hand cycle ride as they arrive ... Flower Hill String Band will present a free concert ... from the Pentagon in Arlington, Virginia. , “We are thrilled ... “These folk have sacrificed so much. We love being to ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Afterglow®, ... light wave technology has just been rated #1 ... Than A Boyfriend.” Developed by urogynecologist Dr. Ralph ... higher levels of arousal by themselves and with ... near-IR light technology to enhance a women's sensual ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Released TranSlice Wipe Exclusively for Final Cut Pro X Editors 2Health News:Healthcare Staffing Agency, Aureus Medical Group, to Exhibit at the Nebraska Academy of Family Physicians Annual Meeting & Scientific Assembly 2Health News:Anthony Grace, MD, PhD, to Deliver Keynote at BioConference Live Neuroscience 2015 2Health News:Anthony Grace, MD, PhD, to Deliver Keynote at BioConference Live Neuroscience 2015 3Health News:Flower Hill String Band to Welcome Face of America with Bluegrass Music 2Health News:Flower Hill String Band to Welcome Face of America with Bluegrass Music 3Health News:Doctor’s Afterglow® Vibrator Enhances Women’s Arousal Using Light Waves, Ranks #1 In "Sex Toys That Are Better Than A Boyfriend" 2
... Day of Fall, September 22, Focuses on Preventing ... Today Congress issued,another call to action urging government, ... prevent the increasing number of falls,among people 65 ... (D-MD),and Mike Enzi (R-WY), as well as Representatives ...
... the 2006 Medicare Current Beneficiary Survey, WASHINGTON, ... option for low and moderate income seniors and ... data from the Medicare,Current Beneficiary Survey (MCBS)., ... and those,living in rural areas, rely on Medigap ...
... Olympic Games Champion Nikki Stone and Chronic Pain ... 22 The American Society of Pain,Educators (ASPE) ... Is Your Persistent Chronic Pain Weighing You Down? ... of proper,weight control in managing chronic pain., ...
... therapy delivered in only a week , , MONDAY, Sept. ... radiosurgery may be a viable treatment for recurring pancreatic ... Center, using their precise CyberKnife to perform radiosurgery, had ... the date of treatment. The range of survival was ...
... babies. , Now, it appears how infants respond to stress ... certain gene, according to a new study from the University of ... say they have also found that good parenting as early ... counter the effect the gene has in babies who initially do ...
... Enables SPECT Procedures ... New ASNC Technology Standards, POWAY, Calif., Sept. 22 ... imaging systems and,services to physicians, offices, hospitals and other medical ... Drug,Administration (FDA) 510(k) clearance for its new nSPEED(R) reconstruction,software -- ...
Cached Medicine News:Health News:Home Safety Council(R) Applauds Creation of Falls Prevention Awareness Day 2Health News:New Webcast Going for Gold to Educate on Importance of Healthy Diet In Persistent Chronic Pain Management 2Health News:New Webcast Going for Gold to Educate on Importance of Healthy Diet In Persistent Chronic Pain Management 3Health News:New Webcast Going for Gold to Educate on Importance of Healthy Diet In Persistent Chronic Pain Management 4Health News:New Webcast Going for Gold to Educate on Importance of Healthy Diet In Persistent Chronic Pain Management 5Health News:Radiosurgery Proves Viable for Some Pancreatic Cancers 2Health News:UNC study: Parenting can override effect of genes in how babies respond to stress 2Health News:Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation 2Health News:Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: